Commentary Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.33696/dentistry.3.019
Scalable 3D Screen Printing Technology in Pharmaceutical Manufacturing - High Degree of Freedom in Terms of Drug Choice
Achim Schneeberger1,*, Stefan Seyferth2, Dagmar Fischer2
- 1Laxxon Medical GmbH, Hans-Knöll-Str. 6, 07745 Jena, Germany
- 2Pharmaceutical Technology, Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Cauerstr. 4, 91058 Erlangen, Germany
Corresponding Author
Achim Schneeberger, a.schneeberger@laxxon-medical.com
Received Date: March 25, 2021
Accepted Date: April 21, 2021
Schneeberger A, Seyferth S, Fischer D. Scalable 3D Screen Printing Technology in Pharmaceutical Manufacturing - High Degree of Freedom in Terms of Drug Choice. Arch Dent. 2021; 3(1):19-21.
Copyright: © 2021 Schneeberger A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Quantifying Respiratory Airborne Particle Dispersion Control Through Improvised Reusable Masks: The Physics of Non-Pharmaceutical Interventions for Reducing SARS-CoV-2 (COVID-19) Airborne Transmission
In light of the current pandemic from rapid transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) and significant morbidity, there has been inconsistent medical guidance given to the public regarding the wearing of non-medical improvised fabric masks or face coverings to reduce the transmission of COVID-19.
Scalable 3D Screen Printing Technology in Pharmaceutical Manufacturing - High Degree of Freedom in Terms of Drug Choice
Additive manufacturing has the potential to revolutionize the pharmaceutical industry, enabling the production of customized drugs for the mass market. However, concerns over scalability, low mechanical resistance, low printing resolution and limited material choices have so far hindered the practical application of current 3D printing (3DP) technologies. Although conceptually similar, each uses its own method to deposit and cure the material.
Application of Halides Complexes of Ruthenium (II) in Metallopharmaceuticals and in Material Science: Part-I
Ruthenium readily forms coordinate-complexes and these complexes have their applications in diverse fields. A survey of literature shows that designing of new ligands that can be complexed with Ruthenium (Ru) in various oxidation states can lead to development of new materials with diverse applications.
Could the Norms for International Radiation Protection Be a Model for Pharmaceuticals?
There is no international norm-setting mechanism for pharmaceutical registration. By contrast, the International Commission on Radiological Protection (ICRP) has been recommending widely respected norms for X-rays and radioactive isotopes in medical and other uses for almost a century. It does so with no legal authority on the basis of collaborative deliberations by a self-selected group that includes experts concerned about both health effects and the benefits of ionizing radiation.